Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 117

1.

Optimization of heart allocation: The transplant risk score.

Jasseron C, Legeai C, Jacquelinet C, Nubret-Le Coniat K, Flécher E, Cantrelle C, Audry B, Bastien O, Dorent R.

Am J Transplant. 2018 Dec 2. doi: 10.1111/ajt.15201. [Epub ahead of print]

PMID:
30506840
2.

Prognostic impact of blood product transfusion in VA and VV ECMO.

Guimbretière G, Anselmi A, Roisne A, Lelong B, Corbineau H, Langanay T, Flécher E, Verhoye JP.

Perfusion. 2018 Nov 16:267659118814690. doi: 10.1177/0267659118814690. [Epub ahead of print]

PMID:
30444173
3.

Predictors and Clinical Impact of Late Ventricular Arrhythmias in Patients With Continuous-Flow Left Ventricular Assist Devices.

Galand V, Flécher E, Auffret V, Boulé S, Vincentelli A, Dambrin C, Mondoly P, Sacher F, Nubret K, Kindo M, Cardi T, Gaudard P, Rouvière P, Michel M, Gourraud JB, Defaye P, Chavanon O, Verdonk C, Ghodbane W, Pelcé E, Gariboldi V, Pozzi M, Obadia JF, Litzler PY, Anselme F, Babatasi G, Belin A, Garnier F, Bielefeld M, Hamon D, Radu C, Pierre B, Bourguignon T, Eschalier R, D'Ostrevy N, Bories MC, Marijon E, Vanhuyse F, Blangy H, Verhoye JP, Leclercq C, Martins RP; ASSIST-ICD Investigators.

JACC Clin Electrophysiol. 2018 Sep;4(9):1166-1175. doi: 10.1016/j.jacep.2018.05.006. Epub 2018 Jul 25.

PMID:
30236390
4.

Antiarrhythmic Drugs Are not the Only Option in Electrical Storm: Extracorporeal Membrane Oxygenation as a Life-saving Alternative.

Martins RP, Flecher E, Le Pennec-Prigent S, Galand V.

Rev Esp Cardiol (Engl Ed). 2019 Feb;72(2):184. doi: 10.1016/j.rec.2018.08.007. Epub 2018 Aug 25. English, Spanish. No abstract available.

PMID:
30150139
5.

Hemodynamic Results and Mid-term Follow-up of 850 19 to 23 mm Perimount Magna Ease Valves.

Anselmi A, Ruggieri VG, Soulami RB, Flécher E, Langanay T, Corbineau H, Leguerrier A, Verhoye JP.

Thorac Cardiovasc Surg. 2018 Aug 1. doi: 10.1055/s-0038-1660517. [Epub ahead of print]

PMID:
30068000
6.

Pulmonary hypertension in chronic heart failure: definitions, advances, and unanswered issues.

Berthelot E, Bauer F, Eicher JC, Flécher E, Gellen B, Guihaire J, Guijarro D, Roul G, Salvat M, Tribouilloy C, Zores F, Lamblin N, de Groote P, Damy T.

ESC Heart Fail. 2018 Oct;5(5):755-763. doi: 10.1002/ehf2.12316. Epub 2018 Jul 20. Review.

7.

[Non-infective endocarditis].

Le Bot A, Jégo P, Donal E, Flécher E, Revest M, Tattevin P.

Rev Med Interne. 2018 Oct;39(10):782-791. doi: 10.1016/j.revmed.2018.03.020. Epub 2018 Jun 11. Review. French.

PMID:
29903680
8.

Conventional aortic valve replacement in 2005 elderly patients: a 32-year experience.

Langanay T, Rouzé S, Tomasi J, Aymami M, Rehman SM, Anselmi A, Corbineau H, Flécher E, Logeais Y, Leguerrier A, Verhoye JP.

Eur J Cardiothorac Surg. 2018 Sep 1;54(3):446-452. doi: 10.1093/ejcts/ezy072.

PMID:
29566140
9.

Assessment of potential heart donors: A statement from the French heart transplant community.

Dorent R, Gandjbakhch E, Goéminne C, Ivanes F, Sebbag L, Bauer F, Epailly E, Boissonnat P, Nubret K, Amour J, Vermes E, Ou P, Guendouz S, Chevalier P, Lebreton G, Flecher E, Obadia JF, Logeart D, de Groote P.

Arch Cardiovasc Dis. 2018 Feb;111(2):126-139. doi: 10.1016/j.acvd.2017.12.001. Epub 2017 Dec 23. Review.

10.

Predictors and prognostic impact of new left bundle branch block after surgical aortic valve replacement.

Khounlaboud M, Flécher E, Fournet M, Le Breton H, Donal E, Leclercq C, Mabo P, Leguerrier A, Daubert C.

Arch Cardiovasc Dis. 2017 Dec;110(12):667-675. doi: 10.1016/j.acvd.2017.03.007. Epub 2017 Sep 28.

11.

Long-term follow-up of bioprosthetic aortic valve replacement in patients aged ≤60 years.

Anselmi A, Flecher E, Chabanne C, Ruggieri VG, Langanay T, Corbineau H, Leguerrier A, Verhoye JP.

J Thorac Cardiovasc Surg. 2017 Nov;154(5):1534-1541.e4. doi: 10.1016/j.jtcvs.2017.05.103. Epub 2017 Jun 12.

PMID:
28688707
12.

Device-specific evaluation of intraventricular left ventricular assist device position by quantitative coaxiality analysis.

Anselmi A, Collin S, Haigron P, Verhoye JP, Flecher E.

J Surg Res. 2017 Jun 1;213:110-114. doi: 10.1016/j.jss.2017.02.027. Epub 2017 Feb 28.

13.

Clinical outcomes in patients after extracorporeal membrane oxygenation support for post-cardiotomy cardiogenic shock: a single-centre experience of 92 cases.

Guihaire J, Dang Van S, Rouze S, Rosier S, Roisne A, Langanay T, Corbineau H, Verhoye JP, Flécher E.

Interact Cardiovasc Thorac Surg. 2017 Sep 1;25(3):363-369. doi: 10.1093/icvts/ivx155.

PMID:
28575211
14.

Machine learning to support decision-making for cardiac surgery during the acute phase of infective endocarditis.

Donal E, Flecher E, Tattevin P.

Heart. 2017 Sep;103(18):1396-1397. doi: 10.1136/heartjnl-2017-311512. Epub 2017 May 8. No abstract available.

PMID:
28483984
15.

Heart transplantation in selected patients aged 60 years and older: a two-decade retrospective and multicentre analysis.

Bosseau C, Lelong B, Pattier S, Trochu JN, Roussel JC, Sirinelli A, Aupart M, Chabanne C, Dorent R, Cantrelle C, Mabo P, Leclercq C, Verhoye JP, Flécher E.

Eur J Cardiothorac Surg. 2017 May 1;51(5):893-901. doi: 10.1093/ejcts/ezx040.

PMID:
28329396
16.

Pre- and postoperative tricuspid regurgitation in patients with severe symptomatic aortic stenosis: importance of pre-operative tricuspid annulus diameter.

Dumont C, Galli E, Oger E, Fournet M, Flecher E, Leclercq C, Verhoye JP, Donal E.

Eur Heart J Cardiovasc Imaging. 2018 Mar 1;19(3):319-328. doi: 10.1093/ehjci/jex031.

PMID:
28329333
17.

Impact of donor comorbidities on heart transplant outcomes in the modern era.

Guihaire J, Noly PE, Martin A, Rojo M, Aymami M, Ingels A, Lelong B, Chabanne C, Verhoye JP, Flécher E.

Interact Cardiovasc Thorac Surg. 2017 Jun 1;24(6):898-904. doi: 10.1093/icvts/ivx014.

PMID:
28329066
18.

Left ventricular assist device-related infections: a multicentric study.

Siméon S, Flécher E, Revest M, Niculescu M, Roussel JC, Michel M, Leprince P, Tattevin P.

Clin Microbiol Infect. 2017 Oct;23(10):748-751. doi: 10.1016/j.cmi.2017.03.008. Epub 2017 Mar 18.

19.

Venous stent in liver transplant candidates: Dodging the top tip traps.

Merdrignac A, Jeddou H, Houssel-Debry P, Flecher E, Rayar M, Boudjema K.

Liver Transpl. 2017 Jul;23(7):972-975. doi: 10.1002/lt.24748. No abstract available.

20.

Brief Report: Proteasomal Indoleamine 2,3-Dioxygenase Degradation Reduces the Immunosuppressive Potential of Clinical Grade-Mesenchymal Stromal Cells Undergoing Replicative Senescence.

Loisel S, Dulong J, Ménard C, Renoud ML, Meziere N, Isabelle B, Latour M, Bescher N, Pedeux R, Bertheuil N, Flecher E, Sensebé L, Tarte K.

Stem Cells. 2017 May;35(5):1431-1436. doi: 10.1002/stem.2580. Epub 2017 Feb 23.

Supplemental Content

Loading ...
Support Center